Skip to main content

ConvaTec Group PLC Value Stock - Dividend - Research Selection

ConvaTec Group PLC

ISIN: GB00BD3VFW73, WKN: A2AUD3

Market price date: 12.01.2021
Market price: 2,75 USD




ConvaTec Group PLC Fundamental data and company key figures of the share

Annual reports in USD
Key figures 02-03-2020
Cash flow
Net operating cash flow 401.800.000
Capital Expenditures -61.400.000
Free cash flow 340.400.000
Balance sheet
Total Equity 1.561.000.000
Liabilities & Shareholders equity 3.609.800.000
Income statement
Net income 9.800.000
Eps (diluted) 0,005
Diluted shares outstanding 1.970.000.000
Net sales/revenue 1.827.200.000

Fundamental ratios calculated on: 12-01-2021

Ratios
Key figures 12-01-2021
Cash flow
P/C 13,48
   
P/FC 15,92
Balance sheet
ROI0,27
ROE43,24
Income statement
P/E553,32
Div. Yield0,00%
P/B3,47
P/S2,97


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolCTEC.L
Market Capitalization5.476.599.808,00 USD
CountryUnited Kingdom
IndicesNO INDEX
SectorsHealth service
Raw Data SourceIFRS in Millionen USD
Stock Split
Internetconvatecgroup.com


Description of the company

ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes. The company also provides a portfolio of wound dressings that include antimicrobial and foam dressings to manage chronic wounds comprising pressure, venous leg, and diabetic foot ulcers. In addition, it offers devices, accessories, and services consisting of Esteem+ one-piece and Natura+ two-piece advanced pouch ranges for people with an ostomy or stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. Further, the company provides continence and critical care products, including intermittent urinary catheters; advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and a range of disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, and gastroenterology tubes. Additionally, it offers disposable infusion sets to the suppliers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and a range of products to hospitals and the home healthcare sector. The company markets its products through internal sales force, distributors, wholesalers, hospitals, specialist medical stores, pharmacies, and homecare agencies. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 2008 and is headquartered in Reading, the United Kingdom.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, convatecgroup.com